Diana Spencer reviews the latest high-throughput screening technologies used for drug discovery and how they can accelerate therapeutics to the clinic. High-throughput screening (HTS) utilises robotics and automation to allow testing of large numbers of chemical and/or biological compounds for a specific biological target. HTS compatible cellular assays Robert G Lowery PhD, President & CEO […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!